| Literature DB >> 35683011 |
Xue-Yi Hu1,2,3, Xiao-Ming Li1,2, Bin-Gui Wang1,2,3,4, Ling-Hong Meng1,2,4.
Abstract
Four unusual steckwaic acids E-H (1-4), possessing a rarely described acrylic acid unit at C-4 (1-3) or a double bond between C-12 and C-13 (4) are reported for the first time, along with four new analogues (5-8) and two known congeners (9 and 10). They were purified from the organic extract of Penicillium steckii AS-324, an endozoic fungus obtained from a deep-sea coral Acanthogorgiidae sp., which was collected from the Magellan Seamount at a depth of 1458 m. Their structures were determined by the interpretation of NMR and mass spectroscopic data. The relative and absolute configurations were determined by NOESY correlations, X-ray crystallographic analysis, and ECD calculations. All compounds were tested for their antimicrobial activities against human- and aquatic-pathogenic bacteria and plant-related pathogenic fungi.Entities:
Keywords: Penicillium steckii; biological activity; marine endozoic fungus; natural products; polyketide derivatives; structure elucidation
Mesh:
Substances:
Year: 2022 PMID: 35683011 PMCID: PMC9181172 DOI: 10.3390/ijms23116332
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Structures of compounds 1–10.
1H and 13C NMR data of compounds 1–3 in DMSO-d6.
| No. | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
| 1 | 167.6, C | 167.4, C | 167.6, C | |||
| 2 | 120.5, CH | 5.71, d (15.4) | 120.1, CH | 5.74, d (15.3) | 120.5, CH | 5.71, d (15.4) |
| 3 | 154.2, CH | 6.84, dd (15.4, 10.9) | 154.2, CH | 6.88, dd (15.3, 10.9) | 153.2, CH | 6.86, dd (15.4, 10.9) |
| 4 | 48.0, CH | 2.46, ddd (10.9, 9.5, 5.6) | 47.5, CH | 2.46, td (10.9, 5.0) | 47.2, CH | 2.45, td (10.9, 5.4) |
| 5 | 44.9, CH | 1.00, q (9.5) | 46.0, CH | 0.98, m | 46.3, CH | 0.88, overlap |
| 6 | 35.8, CH | 2.11, m | 35.7, CH | 1.37, m | 35.4, CH | 1.32, dddq (10.5, 10.1, 3.2, 6.4) |
| 7 | 44.4, CH2 | 1.56, dt (13.7, 3.8) | 40.0, CH2 | 1.81, overlap | 40.5, CH2 | 1.66, dq (14.3, 3.2) |
| 8 | 40.0, CH | 1.35, overlap | 43.2, CH | 2.35, m | 40.0, CH | 1.52, m |
| 9 | 77.0, CH | 2.59, t (9.5) | 35.4, CH2 | 1.93, d (12.3) | 35.8, CH2 | 1.77, overlap |
| 10 | 49.2, CH | 1.67, td (9.5, 2.0) | 41.5, CH | 1.81, overlap | 41.6, CH | 1.77, overlap |
| 11 | 129.4, CH | 6.01, dt (9.8, 2.0) | 131.7, CH | 5.45, br d (9.7) | 131.8, CH | 5.44, dt (9.6, 2.0) |
| 12 | 132.2, CH | 5.58, ddd (9.8, 4.3, 2.0) | 132.6, CH | 5.58, br d (9.7) | 131.9, CH | 5.56, ddd (9.6, 4.4, 2.0) |
| 13 | 36.1, CH | 1.35, overlap | 36.7, CH | 2.15, q (6.1) | 36.3, CH | 2.14, m |
| 14 | 16.6, CH3 | 0.88, d (7.1) | 16.5, CH3 | 0.90, overlap | 16.1, CH3 | 0.90, d (7.0) |
| 15 | 22.3, CH3 | 0.83, overlap | 22.6, CH3 | 0.90, overlap | 22.5, CH3 | 0.88, d (6.4) |
| 16 | 19.2, CH3 | 0.91, d (6.4) | 176.9, C | 66.3, CH2 | 3.20, m | |
| 1-COOH | 12.09, br s | 12.02, br s | ||||
| 9-OH | 4.56, br s | |||||
Detected by HMBC data. Detected by HSQC data.
Figure 2Key COSY (bold lines) and HMBC (arrows) correlations of compounds 1–8.
Figure 3Key NOESY correlations of compounds 1–8.
Figure 4X-ray crystallographic structures of compounds 1 and 2 (with a thermal ellipsoid probability of 50%).
Figure 5ECD spectra of compounds 1–3.
1H and 13C NMR data of compounds 4–6 in DMSO-d6.
| No. | 4 | 5 | 6 | |||
|---|---|---|---|---|---|---|
| 1 | 167.6, C | 167.7, C | 167.8, C | |||
| 2 | 120.6, CH | 5.80, d (15.3) | 120.4, CH | 5.77, d (15.2) | 120.7, CH | 5.79, d (15.3) |
| 3 | 144.2, CH | 7.13, dd (15.3, 10.8) | 144.4, CH | 7.14, dd (15.2, 11.1) | 144.0, CH | 7.11, dd (15.3, 11.0) |
| 4 | 128.8, CH | 6.23, dd (15.1, 10.8) | 129.2, CH | 6.29 dd (15.3, 11.1) | 129.3, CH | 6.31, dd (15.3, 11.0) |
| 5 | 144.9, CH | 6.11, dd (15.1, 9.3) | 148.9, CH | 5.95, overlap | 148.9, CH | 6.00, dd (15.3, 9.4) |
| 6 | 43.6, CH | 2.52, ddd (10.9, 9.3, 2.3) | 49.4, CH | 2.53, m | 49.5, CH | 2.52, m |
| 7 | 49.4, CH | 1.39, dd (10.9, 7.5) | 43.6, CH | 1.19, m | 43.1, CH | 1.29, overlap |
| 8 | 34.5, CH | 1.48, overlap | 34.6, CH | 1.41, overlap | 39.2, CH | 1.57, dd (12.3, 2.9) |
| 9 | 44.7, CH2 | 1.70, m | 48.7, CH2 | 1.41, overlap | 39.5, CH2 | 1.29, overlap |
| 10 | 36.3, CH | 1.48, overlap | 68.0, C | 36.1, CH | 1.71, m | |
| 11 | 44.0, CH2 | 2.14, ddd (12.1, 3.8, 1.8) | 41.9, CH2 | 1.62, overlap | 32.4, CH2 | |
| 12 | 138.8, C | 37.6, CH | 1.62, overlap | 42.2, CH | 1.15, overlap | |
| 13 | 124.2, CH | 5.31, d (2.0) | 75.2, CH | 3.33, m | 65.5, CH | 3.66, d (6.0) |
| 14 | 68.7, CH | 3.59, m | 124.1, CH | 5.95, overlap | 127.1, CH | 5.74, dt (6.0, 1.5) |
| 15 | 36.2, CH | 1.48, overlap | 139.1, C | 136.1, C | ||
| 16 | 15.6, CH3 | 0.90, d (6.8) | 22.0, CH3 | 1.58, s | 21.9, CH3 | 1.52, s |
| 17 | 20.4, CH3 | 0.92, d (6.3) | 21.5, CH3 | 0.81, d (6.6) | 22.1, CH3 | 0.88, d (5.9) |
| 18 | 22.1, CH3 | 0.87, d (6.5) | 31.5, CH3 | 1.08, s | 68.7, CH2 | 3.82, d (6.4) |
| 13-OCH3 | 55.8, CH3 | 3.22, s | ||||
| 19 | 170.4, C | |||||
| 20 | 20.7, CH3 | 2.00, s | ||||
| 1-COOH | 12.12, br s | |||||
Detected by HMBC correlations.
Figure 6Experimental and calculated ECD of compound 4.
Figure 7Experimental and calculated ECD of compound 5.
Figure 8Experimental ECD of compounds 5–10.
1H and 13C NMR data of compounds 7 and 8 in DMSO-d6.
| No. | 7 | 8 | ||
|---|---|---|---|---|
| 1 | 168.8, C | 168.2, C | ||
| 2 | 123.9, CH | 5.82, d (15.4) | 121.2, CH | 5.80, d (15.3) |
| 3 | 141.8, CH | 7.01, dd (15.4, 11.1) | 144.5, CH | 7.12, dd (15.3, 11.0) |
| 4 | 129.6, CH | 6.22, td (11.1, 5.2) | 129.6, CH | 6.28, dd (15.3, 11.0) |
| 5 | 146.6, CH | 5.78, dd (11.1, 5.2) | 149.0, CH | 5.94, dd (15.3, 9.2) |
| 6 | 49.5, CH | 2.53, m | 49.6, CH | 2.57, t (9.2) |
| 7 | 40.0, CH | 1.57, overlap | 48.7, CH | 0.99, m |
| 8 | 42.1, CH | 1.23, overlap | 39.2, CH | 1.37, overlap |
| 9 | 39.2, CH2 | 1.23, overlap | 40.0, CH2 | 1.61, d (12.5) |
| 10 | 39.5, CH | 1.46, m | 39.2, CH | 1.37, overlap |
| 11 | 32.8, CH2 | 1.57, overlap | 32.9, CH2 | |
| 12 | 44.3, CH | 1.23, overlap | 43.8, CH | 1.10, m |
| 13 | 75.3, CH | 3.37, d (6.1) | 80.3, CH | 3.32, d (9.4) |
| 14 | 123.9, CH | 5.91, d (6.1) | 126.3, CH | 5.64, m |
| 15 | 139.4, C | 134.7, C | ||
| 16 | 22.0, CH3 | 1.58, s | 21.9, CH3 | 1.55, s |
| 17 | 22.0, CH3 | 0.87, d (6.5) | 22.9, CH3 | 0.87 d (6.5) |
| 18 | 66.6, CH2 | 3.18, d (6.1) | 66.9, CH2 | 3.19, d (6.2) |
| 13-OCH3 | 55.8, CH3 | 3.22, s | 55.7, CH3 | 3.26, s |
| 18-OH | 4.35, br s | |||
Detected by HMBC correlations.
Antibacterial activities of active compounds 5 and 8−10 (MIC, μg/mL) .
|
|
|
|
| |
|---|---|---|---|---|
|
| - | - | 16 | - |
|
| 64 | 8 | - | - |
|
| - | - | 64 | - |
|
| 16 | - | - | - |
| Chloramphenicol | 2 | 1 | 1 | 2 |
(-) = MIC > 64 μg/mL. Chloramphenicol as positive control.